Giulia Zamagni joins Claudia Schaefer to discuss her recent Series of 4 papers from the Italian Global Burden of Disease collaborators providing the disease burden estimates and temporal trends for leukemia, multiple myeloma, non-Hodgkin lymphoma and Hodgkin lymphoma in Italy. Click here to read the full text in this series: paper 1; paper 2; paper 3; paper 4 Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup...
All content for eClinicalMedicine in conversation with is the property of The Lancet Group and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Giulia Zamagni joins Claudia Schaefer to discuss her recent Series of 4 papers from the Italian Global Burden of Disease collaborators providing the disease burden estimates and temporal trends for leukemia, multiple myeloma, non-Hodgkin lymphoma and Hodgkin lymphoma in Italy. Click here to read the full text in this series: paper 1; paper 2; paper 3; paper 4 Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup...
Anita Lim on self-testing in cervical cancer screening
eClinicalMedicine in conversation with
19 minutes
1 year ago
Anita Lim on self-testing in cervical cancer screening
Dr Anita Lim joins Elena Bellafante, Deputy Editor for eClinicalMedicine, to talk about her recent publication of the YouScreen study, a pragmatic implementation feasibility trial that assessed the impact of offering self-sampling to non-attenders within the English cervical cancer screening programme.Read the full article:https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00251-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_eclinmContinue this conversation on social!Follow u...
eClinicalMedicine in conversation with
Giulia Zamagni joins Claudia Schaefer to discuss her recent Series of 4 papers from the Italian Global Burden of Disease collaborators providing the disease burden estimates and temporal trends for leukemia, multiple myeloma, non-Hodgkin lymphoma and Hodgkin lymphoma in Italy. Click here to read the full text in this series: paper 1; paper 2; paper 3; paper 4 Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup...